EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease

Giacomo Argenziano, Giovanna Squintani, Serena Camozzi, Ilaria Di Vico, Marialuisa Gandolfi iD, Carlo Alberto Artusi iD, Michele Tinazzi iD, Christian Geroin iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Giacomo Argenziano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Botulinum Toxins, Type A, Neuromuscular Agents, Sensation Disorders. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Axial postural abnormalities (APAs) are common, disabling complications of Parkinson's disease (PD) with unclear pathophysiology. The presence of hyperactivity in multiple trunk muscles supports the use of botulinum toxin (BTA). However, its application is complex, due to the lack of standardized clinical and electrophysiological approach.

Objectives

To evaluate BTA injections effectiveness using a clinical algorithm that integrates trunk angle severity and electromyography (EMG)‐detected muscle hyperactivity in patients with APAs.

Methods

This is prospective, open‐label, pilot study. A novel decisional algorithm guided muscle selection, based on the bending degree and EMG findings. PD patients with different APAs underwent trunk angle measurement and EMG polygraphy of axial muscles in the standing position and during trunk activation. Primary outcome was the change in trunk misalignment measured before and one month after BTA injection. Secondary outcomes were the Clinical Global Impression of Change‐Improvement (CGI‐pain and CGI‐posture) and the Numeric Rating Scale (NRS) for pain.

Results

Among 52 PD patients, 20(38.5%) were eligible for treatment. At one‐month follow‐up, lateral trunk flexion (LTF) improved [LTF angle from 11.5 (CI 7.1–15.9) to 9.9, (CI 5.2–14.7) P = 0.013], while anterior trunk flexion (ATF) did not (thoracic fulcrum ATF from 41.4 to 40.6, P > 0.05; lumbar fulcrum ATF from 25.7 to 24.5, P > 0.05). CGI‐posture improved in 45% of cases, CGI‐pain improved in 50% of cases, and NRS decreased from 6.3 to 4.8 ( P = 0.010).

Conclusions

A clinical and neurophysiological algorithm integrating measures of trunk bending and EMG‐detected muscle hyperactivity can optimize BTA treatment for APAs in PD, improving motor/ non‐motor outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseBotulinum Toxins, Type ANeuromuscular AgentsSensation DisordersPostural BalanceDecision Making, Computer-AssistedProspective StudiesTreatment OutcomeTorsoMuscle, SkeletalSeverity of Illness IndexElectromyographyHumansMaleFemaleMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

EMG polygraphyPisa syndromeaxial postural abnormalitiesbotulinum toxincamptocormia

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Neurology and Neurophysiology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
  • Neurology 2 Unit, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

ORCID-Profile: Marialuisa Gandolfi, Carlo Alberto Artusi, Michele Tinazzi, Christian Geroin

Zitieren

APA

Argenziano, G., Squintani, G., Camozzi, S., Di Vico, I., Gandolfi, M., Artusi, C. A., Tinazzi, M., & Geroin, C. (2025). Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70408

Vancouver

Argenziano G, Squintani G, Camozzi S, Di Vico I, Gandolfi M, Artusi CA, et al. Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70408

BibTeX
@article{Argenziano2025,
  author = {Argenziano, Giacomo and Squintani, Giovanna and Camozzi, Serena and Di Vico, Ilaria and Gandolfi, Marialuisa and Artusi, Carlo Alberto and Tinazzi, Michele and Geroin, Christian},
  title = {Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70408}
}
Kostenlos starten →